Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

KILITCH DRUGS (INDIA) LTD. - 524500 - Disclosure Of Related Party Transaction Pursuant To Regulation 23(9) Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 For Period Ended 31St March, 2020.

 Pursuant to Regulation 23(9) of Securities Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015, please find enclosed herewith disclosure of Related Party Transaction on consolidated basis for the half year ended 31st March, 2020, in the format specified on the relevant accounting standards. Kindly take the same into your records.
30-07-2020
Bigul

KILITCH DRUGS (INDIA) LTD. - 524500 - Shareholding for the Period Ended June 30, 2020

 Kilitch Drugs India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2020. For more details, kindly Click here
20-07-2020
Bigul

KILITCH DRUGS (INDIA) LTD. - 524500 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 We are enclosing herewith certificate issued by the Registrar & Share Transfer Agent M/s. Link Intime India Private Limited confirming the compliance of Regulation 74 (5) of SEBI (Depositories and Participants) Regulations, 2018.
18-07-2020
Bigul

KILITCH DRUGS (INDIA) LTD. - 524500 - Statement Of Investor Complaints For The Quarter Ended June 2020

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Mukund MehtaDesignation :- Managing Director / Whole Time Director
15-07-2020
Bigul

Annual report for Kilitch Drugs(I) Ltd. for FY-2020
01-07-2020
Bigul

KILITCH DRUGS (INDIA) LTD. - 524500 - OUTCOME OF BOARD MEETING

 Outcome of Board Meeting
30-06-2020
Bigul

KILITCH DRUGS (INDIA) LTD. - 524500 - Closure of Trading Window

 Closure of Trading Windows for Insiders of the Company
30-06-2020
Bigul

KILITCH DRUGS (INDIA) LTD. - 524500 - Board Meeting Intimation for To Consider And Approve The Standalone And Consolidated Audited Financial Result Of The Company For The Quarter And Financial Year Ended 31St March 2020

 KILITCH DRUGS (INDIA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/06/2020 ,inter alia, to consider and approve the Standalone and Consolidated Audited Financial Result of the Company for the quarter and financial year ended 31st March 2020.
25-06-2020
Bigul

KILITCH DRUGS (INDIA) LTD. - 524500 - Compliances-Reg.24(A)-Annual Secretarial Compliance

 Pursuant to Regulation 24A of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015, as amended we are forwarding herewith the Annual Secretarial Compliance Report for the financial year 2019-20.
20-06-2020
Bigul

KILITCH DRUGS (INDIA) LTD. - 524500 - Reply To The Clarification Sought On Price Movement Of The Shares Of The Company

 Reply to the Clarification sought on price movement of the shares of the Company
15-06-2020
Next Page
Close

Let's Open Free Demat Account